M. Meuleman

Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series

E. Thervet, P. Bruneval, J. Goujon, 2022, American Journal of Kidney Diseases.

Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome

Z. Massy, K. Dahan, E. Daugas, 2021, Journal of Nephrology.

Ex Vivo Complement Activation on Endothelial Cells: Research and Translational Value.

V. Frémeaux-Bacchi, L. Roumenina, S. Chauvet, 2021, Trends in molecular medicine.

Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases.

S. Chauvet, M. Meuleman, A. Grunenwald, 2022, Seminars in immunology.

Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside

V. Frémeaux-Bacchi, L. Roumenina, S. Chauvet, 2022, Frontiers in Immunology.

Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits

A. Moktefi, V. Audard, M. Meuleman, 2021, Diagnostics.

C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features.

E. Daugas, E. Thervet, V. Frémeaux-Bacchi, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN

E. Thervet, C. Dossier, N. Jourde-Chiche, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Complement involvement in sickle cell disease.

L. Roumenina, M. Meuleman, Anne Grunenwald, 2023, Presse medicale.